-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q1 2025.
- Ionis Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2025 was -$147M, a 2.9% decline year-over-year.
- Ionis Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2025 was -$458M, a 19% decline year-over-year.
- Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$454M, a 23.9% decline from 2023.
- Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$366M, a 35.8% decline from 2022.
- Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$270M, a 843% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)